The principal findings of this study are that plasma Nt-proBNP levels are lower in CHF patients with metabolic syndrome attributable to inverse relationships between plasma Nt-proBNP and BMI, plasma triglyceride and insulin resistance (HOMA-IR). This evidence concerns the gene NPPB and Insulin resistance.